AI tools promise that anyone can build apps, so I put that claim to the test. After a few minor bumps, I built a custom ...

Maintainers and developers are now using AI to help build Linux. Simultaneously, Rust has graduated to being a co-equal language with C for mainstream Linux development. However, the programming world ...

USB-C is everywhere in 2025. If you've felt like every new device you buy, from smartphones to laptops and tablets, uses a USB-C port for charging, you're not imagining things. USB-C has quickly ...

Replimune received FDA acceptance for its RP1 BLA resubmission in advanced melanoma, with a PDUFA date set for April 2026. REPL stock surged nearly 100% on the news, but FDA acceptance only restarts ...

Shares of Replimune Group, Inc. (NASDAQ:REPL) are rising Monday after the clinical stage biotechnology company shared an important regulatory update. What To Know: Replimune said the U.S. Food and ...

The White House said Tuesday it will use money from tariff revenue to fund a supplemental nutrition program facing a funding shortage amid the ongoing government shutdown. White House press secretary ...

ChatGPT adoption is accelerating at a scale rarely seen in technology. By mid-2025, around 700 million people worldwide were using it every week, sending 18 billion messages, which is roughly 10% of ...

The fate of a once-promising cancer treatment now looks uncertain at best. The meeting was conducted with U.S. Food and Drug Administration (FDA) officials, and it took place on Tuesday. The subject ...

We may receive a commission on purchases made from links. Apple's Lightning port on older iPhone devices is reasonably capable, but it pales in comparison to the USB-C port, particularly when paired ...

OKLAHOMA CITY (KFOR) – Artificial intelligence is reportedly making its way into a traditional Medicare pilot program that six states, including Oklahoma, will test out. It has to do with patients ...

Starting in January, Medicare will test out an artificial intelligence (AI) pilot program to decide whether patients get certain procedures covered or not. The Centers for Medicare & Medicaid Services ...

Shares of Replimune (NASDAQ:REPL) plunged ~38% in the premarket on Monday after Stat News reported that the FDA’s top regulator of cancer drugs intervened during the review of the company’s lead asset ...